Simon, Christopher Haemonetics Corp (HAE) insider trading activity

Simon, Christopher is President & CEO of HAEMONETICS CORP. Currently has a direct ownership of 375,544 shares of HAE, which is worth approximately $28.7 Million. The most recent transaction as insider was on May 30, 2025, when has been sold 26,234 shares (Common Stock) at a price of $69.38 per share, resulting in proceeds of $1,820,114. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 376K

16.33% 3M change

3.59% 12M change

Total Value Held $28.7 Million

Simon, Christopher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2025	SELL Payment of exercise price or tax liability	$1,820,114 $69.38 p/Share	26,234 Reduced 6.53%	375,544 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	-	66,666 Added 14.23%	401,778 Common Stock
May 16 2025	SELL Payment of exercise price or tax liability	$498,427 $70.31 p/Share	7,089 Reduced 2.21%	313,707 Common Stock
May 16 2025	BUY Grant, award, or other acquisition	-	21,405 Added 6.0%	335,112 Common Stock
May 15 2025	SELL Payment of exercise price or tax liability	$165,887 $69.38 p/Share	2,391 Reduced 0.74%	320,796 Common Stock
Aug 29 2024	SELL Other acquisition or disposition	$3,000,034 $75.56 p/Share	39,704 Reduced 10.95%	322,838 Common Stock
Jun 06 2024	SELL Payment of exercise price or tax liability	$6,233,252 $87.38 p/Share	71,335 Reduced 16.44%	362,542 Common Stock
Jun 06 2024	BUY Exercise of conversion of derivative security	$4,352,046 $41.64 p/Share	104,516 Added 19.41%	433,877 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$3,995,387 $95.73 p/Share	41,736 Reduced 11.25%	329,361 Common Stock
May 28 2024	BUY Grant, award, or other acquisition	-	106,062 Added 22.23%	371,097 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$386,462 $95.73 p/Share	4,037 Reduced 1.59%	250,411 Common Stock
May 17 2024	BUY Grant, award, or other acquisition	-	14,624 Added 5.23%	265,035 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$180,783 $94.8 p/Share	1,907 Reduced 0.74%	254,448 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$142,805 $96.49 p/Share	1,480 Reduced 0.57%	256,355 Common Stock
Mar 11 2024	SELL Bona fide gift	-	38,900 Reduced 13.12%	257,546 Common Stock
Jun 29 2023	SELL Payment of exercise price or tax liability	$9,982,868 $84.84 p/Share	117,667 Reduced 28.41%	296,446 Common Stock
Jun 29 2023	BUY Exercise of conversion of derivative security	$5,628,903 $28.61 p/Share	196,746 Added 32.21%	414,113 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$319,942 $83.34 p/Share	3,839 Reduced 1.74%	217,367 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$141,487 $89.21 p/Share	1,586 Reduced 0.71%	221,206 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	18,225 Added 7.56%	222,792 Common Stock
May 12 2023	SELL Payment of exercise price or tax liability	$75,288 $88.16 p/Share	854 Reduced 0.42%	204,567 Common Stock
Nov 11 2022	SELL Bona fide gift	-	8,600 Reduced 4.02%	205,124 Common Stock
Jun 13 2022	SELL Open market or private sale	$71,865 $62.6 p/Share	1,148 Reduced 0.53%	213,724 Common Stock
May 19 2022	SELL Open market or private sale	$147,514 $59.1 p/Share	2,496 Reduced 1.15%	214,872 Common Stock
May 16 2022	SELL Open market or private sale	$46,675 $56.1 p/Share	832 Reduced 0.43%	191,327 Common Stock

Also insider at

SHC

Sotera Health Co Healthcare